Cindella injection
Thioctic acid
Negotiable Min Order Quantity 1000 Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Brand name
- Cindella injection
- Payment Terms
- T/T
- Production method
- Available
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- thioctic acid, cindella, daehan new pharm, thioctic
- Category
- Beauty , Health Products , Pharmaceuticals , Medicines , Other Pharmaceuticals
Daehan Nupharm Co., Ltd.
- Recent Visit
- Nov 21, 2024
- Country / Year Established
-
South Korea
/
1984
- Business type
- Manufacturer
- Verified Certificate
-
16
| Product name | Cindella injection | Certification | - |
|---|---|---|---|
| Category |
Beauty
Health Products Pharmaceuticals Medicines Other Pharmaceuticals |
Ingredients | THIOCTICACID |
| Keyword | thioctic acid , cindella , daehan new pharm , thioctic | Unit Size | 23.0 * 9.0 * 2.0 cm |
| Brand name | Cindella injection | Unit Weigh | 114 g |
| origin | South Korea | Stock | 1000 |
| Supply type | Available | HS code | 300490 |
Product Information
Daehan Nupharm (Daehan New Pharm) is a manufacturer of the product.
The product is manufactured in accordance with the Good Manufacturing Practice (GMP).
Active ingredient
Thioctic acid 5mg/mL
Description
A pale yellow, clear injection solution in a brown ampoule
Indication
- When demand for thioctic acid is increased (during intense physical labor)
- Leigh syndrome (subacute necrotizing encephalomyelitis)
- Addictive (due to streptomycin and kanamycin)
- Noise-induced (occupational)
- Otic-resistant hearing loss
Administration / Dosage
As thioctic acid, 10 to 25mg once a day for adults is usually injected intravenously.
Storage
Store in hermetic container at the room temperature (1~30℃).
Shelf life
24 months from the manufacturing date
Packing unit
5mL X 10 ampoules / Box
Packing unit
5mL X 10 ampoules / Box
B2B Trade
| Price (FOB) | Negotiable | transportation | Air Transportation,Ocean Shipping |
|---|---|---|---|
| MOQ | 1000 | Leadtime | Negotiable |
| Payment Options | T/T | Shipping time | Negotiable |
- President
- Wanjin Lee
- Address
- Hyangnam-eup, Jeyakgongdan 1-gil,66, Hwaseong-si, Gyeonggi-do, Korea
- Year Established
- 1984
- No. of Total Employees
- 101-500
- Company introduction
-
Founded in 1984, Daehan New Pharm is a KOSDAQ-listed biopharmaceutical company that started with animal feed additives and veterinary medicine business, expanded to human medicine business in 1994, bio business in 2012, and medical device business in 2014.
Daehan New Pharm, which is continuously growing based on the management philosophy of ‘creating values that can be shared by people with health and warmth,’ is showing remarkable growth, achieving sales of 166.5 billion won in 2021 and a CAGR of 15% over the past 10 years. In addition, Daehan New Pharm has been exporting more than 10 billion won every year since winning the ‘$10 Million Dollar Export Award’ in 2015.
Daehan New Pharm is expanding the R&D pipeline to launch a variety of dietary supplements, and are conducting research and development of differentiated high-quality raw ingredients and formulations.
In order to secure future growth engines in the divisions of dietary supplement, human medicine, veterinary medicine, and bio, Daehan New Pharm Industry-University-Research Center was built in Pangyo 2nd Techno Valley in 2021, and the central research center in Hwaseong and the bio research center in Osong were moved to Pangyo for R&D capabilities to create synergies between the business divisions.
- Main Product
- Attached File
